Literature DB >> 1920626

Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro.

G Palladino1, P A Scherle, W Gerhard.   

Abstract

The activity of distinct CD4+ T-helper cell (Th) clones in promoting secondary A/PR/8/34/Mt.S.(H1N1) (A/PR8) influenza virus-specific, class I-restricted cytotoxic T-lymphocyte (CTL) responses in vitro was examined. CD8+ T cells which had been purified by fluorescence-activated cell sorter from spleen cells of A/PR8-primed mice were used as responders. On their own, purified CD8+ T cells were unable to generate cytotoxic activity upon in vitro culture with A/PR8-infected stimulator cells. Significant cytotoxic activity was generated in cultures that were additionally supplemented with A/PR8-specific Th clones or cell-free supernatant from these clones. Although there were large differences among individual Th clones in this function, Th clones of type 1 (Th1) promoted, on average, significantly stronger cytotoxic responses than Th clones of type 2 (Th2). The differences in promotion of a cytotoxic response correlated with the amount of interleukin-2 (IL-2) or IL-4 secreted by individual Th clones. These two lymphokines accounted for the CTL-promoting activity of the respective Th clones, since addition of recombinant IL-2 (IL-2) or rIL-4 to Th-free cultures substituted fully for the respective Th clones. As observed with Th clones, rIL-2 was significantly more effective than rIL-4 in promoting a cytotoxic response. When used in combination, Th2 clones had an antagonistic effect on the generation of a CTL response by Th1 clones. This effect could be partially transferred with cell-free supernatant from activated Th2 clones and could be reversed by addition of excess rIL-2. Both consumption of IL-2 by Th2 and secretion of an inhibitory factor(s) appear to be involved in this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920626      PMCID: PMC250279     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus.

Authors:  T Mizuochi; A W Hügin; H C Morse; A Singer; R M Buller
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

2.  IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity.

Authors:  D W Horohov; J A Crim; P L Smith; J P Siegel
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

3.  Interleukin 4 (BSF-1) induces growth in resting murine CD8 T cells triggered via cross-linking of T3 cell surface structures.

Authors:  T Miethke; R Schmidberger; K Heeg; S Gillis; H Wagner
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

4.  Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.

Authors:  C J Boog; J Boes; C J Melief
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

5.  T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses.

Authors:  R Ahmed; L D Butler; L Bhatti
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes.

Authors:  K Takatsu; Y Kikuchi; T Takahashi; T Honjo; M Matsumoto; N Harada; N Yamaguchi; A Tominaga
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes.

Authors:  G Trenn; H Takayama; J Hu-Li; W E Paul; M V Sitkovsky
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

9.  Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products.

Authors:  M Wysocka; J R Bennink
Journal:  Cell Immunol       Date:  1988-04-01       Impact factor: 4.868

10.  Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.

Authors:  H Karasuyama; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  13 in total

1.  CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

Authors:  Aprille Seidel; David Smith; Edward Yung; Lia Aquino; Tumul Srivastava; Vinod Pullarkat; Ricardo Spielberger; Stephen J Forman; Don J Diamond
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-08       Impact factor: 5.742

Review 2.  Influenza vaccine responses in older adults.

Authors:  Janet E McElhaney
Journal:  Ageing Res Rev       Date:  2010-11-03       Impact factor: 10.895

3.  CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

Authors:  M G von Herrath; M Yokoyama; J Dockter; M B Oldstone; J L Whitton
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins.

Authors:  S Hou; X Y Mo; L Hyland; P C Doherty
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 5.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

6.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Authors:  Wilbur H Chen; Alan S Cross; Robert Edelman; Marcelo B Sztein; William C Blackwelder; Marcela F Pasetti
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

7.  Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.

Authors:  Janet E McElhaney
Journal:  Aging health       Date:  2008-12-01

8.  Assessment of markers of the cell-mediated immune response after influenza virus infection in frail older adults.

Authors:  J E McElhaney; S Gravenstein; P Krause; J W Hooton; C M Upshaw; P Drinka
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

9.  Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.

Authors:  B P Mahon; K Katrak; K H Mills
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection.

Authors:  M B Graham; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.